FOLFIRI® and bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms.
Bécouarn Y, Cany L, Pulido M, Beyssac R, Texereau P, Le Morvan V, Béchade D, Brunet R, Aitouferoukh S, Lalet C, Mathoulin-Pélissier S, Fonck M, Robert J.
Bécouarn Y, et al. Among authors: brunet r.
BMC Res Notes. 2014 Apr 23;7:260. doi: 10.1186/1756-0500-7-260.
BMC Res Notes. 2014.
PMID: 24758527
Free PMC article.
Clinical Trial.